Latest Advances in Lipid Nanoparticles (LNPs) for Gene Editing and Cancer Immunotherapy
Latest Advances in Lipid Nanoparticles (lnpdelivery) for Gene Editing and Cancer Immunotherapy (As of May 2025) I. LNP-Driven CRISPR-Cas9 Delivery in Gene Editing 1. Targeting PLK1 in Glioblastoma Technology: Amino-ionizable lipid LNPs encapsulate Cas9 mRNA and sgRNA (targeting PLK1), achieving 70% …